Clinical Trials Browser

Interventional × Pancreatic Cancer Metastatic × Irinotecan × Clear all

NCT04469556 2026-02-20

PASS-01

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

NCT03504423 2023-01-03

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

Phase 3 Completed

528 enrolled 11 charts

Gastrointestinal

Pancreatic Cancer Metastatic